Literature DB >> 22159875

CD70: probably being a therapeutic target in human multiple sclerosis.

Xu Wangdong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22159875     DOI： 10.1007/s00296-011-2112-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  7 in total

1.  PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.

Authors:  Saravanan Kanakasabai; Crystal C Walline; Sharmistha Chakraborty; John J Bright
Journal:  Brain Res       Date:  2010-12-28       Impact factor: 3.252

2.  Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.

Authors:  Won-Woo Lee; Zhi-Zhang Yang; Guangjin Li; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 3.  CD27 and CD70 in T cell and B cell activation.

Authors:  Jannie Borst; Jenny Hendriks; Yanling Xiao
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

4.  Increased prevalence of activated CD70+CD4+ T cells in the periphery of patients with systemic lupus erythematosus.

Authors:  B K Han; A M White; K H Dao; D R Karp; E K Wakeland; L S Davis
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 5.  Death ligands and autoimmune demyelination.

Authors:  Orhan Aktas; Timour Prozorovski; Frauke Zipp
Journal:  Neuroscientist       Date:  2006-08       Impact factor: 7.519

6.  Expression of the murine CD27 ligand CD70 in vitro and in vivo.

Authors:  Kiki Tesselaar; Yanling Xiao; Ramon Arens; Gijs M W van Schijndel; Danita H Schuurhuis; Reina E Mebius; Jannie Borst; René A W van Lier
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

7.  Effects of anti-CD70 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  Satoshi Yanagisawa; Naoya Takeichi; Tomoki Kaneyama; Hideo Yagita; Syun'ichiro Taniguchi; Byung S Kim; Chang-Sung Koh
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.